0001493152-20-012802.txt : 20200708
0001493152-20-012802.hdr.sgml : 20200708
20200708083434
ACCESSION NUMBER: 0001493152-20-012802
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200706
FILED AS OF DATE: 20200708
DATE AS OF CHANGE: 20200708
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Golumbeski George
CENTRAL INDEX KEY: 0001586660
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37348
FILM NUMBER: 201017308
MAIL ADDRESS:
STREET 1: C/O CELGENE CORP.
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Corbus Pharmaceuticals Holdings, Inc.
CENTRAL INDEX KEY: 0001595097
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464348039
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 RIVER RIDGE DRIVE
CITY: NORWOOD
STATE: MA
ZIP: 02062
BUSINESS PHONE: 617-963-0103
MAIL ADDRESS:
STREET 1: 500 RIVER RIDGE DRIVE
CITY: NORWOOD
STATE: MA
ZIP: 02062
FORMER COMPANY:
FORMER CONFORMED NAME: SAV Acquisition Corp
DATE OF NAME CHANGE: 20131220
4
1
ownership.xml
X0306
4
2020-07-06
0
0001595097
Corbus Pharmaceuticals Holdings, Inc.
CRBP
0001586660
Golumbeski George
C/O CORBUS PHARMACEUTICALS
HOLDINGS, INC. 500 RIVER RIDGE DRIVE
SUMMIT
NJ
07901
1
0
0
0
Stock Option(right to buy)
7.91
2020-07-06
4
A
0
81000
0.00
A
2030-07-06
Common Stock
81000
81000
D
The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant.
/s/ George Golumbeski
2020-07-08